As the muscular dystrophies result in progressive pathology of skeletal muscle, long term studies are crucial to determine if proposed treatments will correct the pathology over time and to assess the effect of myostatin inhibition on cardiac function. The gene discussed is MSTN; the disease is muscular dystrophy.